1. Auerbach, D.I., Maeda, J.L., & Steiner, C. (2012). Hospital stays with cardiac stents, 2009, Statistical Brief #128. Healthcare Cost and Utilization Project (HCUP). https://www.ncbi.nlm.nih.gov/books/NBK97358/, retrieved August 13, 2020.
2. Barzel, Y. (1968). Optimal timing of innovations. Review of Economics and Statistics, 50, 348–355.
3. Berchick, E.R., Barnett, J.C., & Upton, R.D. (2019). Health insurance coverage in the United States: 2018, Current Population Reports, P60-267 (RV). U.S. Department of Commerce, Economics and Statistics Administration, U.S. Census Bureau. Washington, DC: U.S. Government Printing Office, retrieved June 21, 2020.
4. Cubanski, J., Neuman, T., True, S., & Freed, M. (2019). What’s the latest on medicare drug price negotiations? Issue Brief. Henry J. Kaiser Family Foundation. https://www.kff.org/medicare/issue-brief/whats-the-latest-on-medicare-drug-price-negotiations/, retrieved May 15, 2020.
5. Danziger, R.S., & Scott, J.T. (2021). Government royalties on sales of pharmaceutical and other biomedical products developed with substantial public funding: Illustrated with the technology transfer of the drug-eluting coronary stent. forthcoming. Annals of Science and Technology Policy, 5.